Cargando…

Effects of personality on the association between paroxetine plasma concentration and response

BACKGROUND: We studied the differences between groups that were divided according to personality characteristics with respect to the relationship between drug concentration and symptom improvement. METHODS: A total of 120 patients with major depressive disorder were treated with paroxetine for 6 wee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomita, Tetsu, Yasui-Furukori, Norio, Nakagami, Taku, Tsuchimine, Shoko, Ishioka, Masamichi, Kaneda, Ayako, Nakamura, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276606/ https://www.ncbi.nlm.nih.gov/pubmed/30568452 http://dx.doi.org/10.2147/NDT.S187060

Ejemplares similares

The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder
por: Tomita, Tetsu, et al.
Publicado: (2014)

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response
por: Tomita, Tetsu, et al.
Publicado: (2014)

An attempt to construct a 7-item short version of the temperament and character inventory to predict the treatment response of patients with depression; a validation study
por: Tomita, Tetsu, et al.
Publicado: (2016)

PS108. Characteristics of escitalopram discontinuation syndrome
por: Norio-Furukori, Yasui, et al.
Publicado: (2016)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2015)

PS104. An attempt to construct a 7-item short version of the Temperament and Character Inventory to predict the treatment response of patients with depression
por: Tomito, Tetsu, et al.
Publicado: (2016)

ABO Blood Type and Personality Traits in Healthy Japanese Subjects
por: Tsuchimine, Shoko, et al.
Publicado: (2015)

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo, Shuhei, et al.
Publicado: (2015)

Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
por: Tsuchimine, Shoko, et al.
Publicado: (2013)

Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders
por: Saruwatari, Junji, et al.
Publicado: (2014)

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan
por: Tsuruga, Koji, et al.
Publicado: (2014)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki, Akiko, et al.
Publicado: (2014)

Dietary patterns are associated with obesity in Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2014)

PS105. Effects of CYP2C19 genotype on steady-state plasma concentrations of escitalopram and desmetyl metabolite in Japanese depressed patients
por: Tsuchimine, Shoko, et al.
Publicado: (2016)

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2014)

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation
por: Tomita, Tetsu, et al.
Publicado: (2018)

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients
por: Tomita, Tetsu, et al.
Publicado: (2018)

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation
por: Tomita, Tetsu, et al.
Publicado: (2019)

Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression
por: Tsuchimine, Shoko, et al.
Publicado: (2018)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

PS91. The effects of fluvoxamine on the steady-state plasma concentrations of escitalopram and desmethylescitalopram in depressed Japanese patients.
por: Kubo, Kazutoshi, et al.
Publicado: (2016)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto, Kojiro, et al.
Publicado: (2014)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka, Masamichi, et al.
Publicado: (2014)

No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan
por: Sugawara, Norio, et al.
Publicado: (2012)

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
por: Kawamata, Yasushi, et al.
Publicado: (2021)

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan
por: Sugawara, Norio, et al.
Publicado: (2017)

Insulinoma resembling a rapid eye movement sleep behavior disorder: a case report
por: Kishi, Kenji, et al.
Publicado: (2019)

The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis
por: Tomita, Tetsu, et al.
Publicado: (2015)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga, Koji, et al.
Publicado: (2015)

Relationship between quality of life and restless legs syndrome among a community-dwelling population in Japan
por: Kubo, Kazutoshi, et al.
Publicado: (2016)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda, Ayako, et al.
Publicado: (2013)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2019)

Interaction between paliperidone extended release and TS-1(®), an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient
por: Yasui-Furukori, Norio, et al.
Publicado: (2013)

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
por: Tomita, Tetsu, et al.
Publicado: (2016)

Body mass index and quality of life among outpatients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2013)

Insomnia in patients on hemodialysis for a short versus long duration
por: Tomita, Tetsu, et al.
Publicado: (2016)

Body composition in patients with schizophrenia: Comparison with healthy controls
por: Sugawara, Norio, et al.
Publicado: (2012)

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
por: Saruwatari, Junji, et al.
Publicado: (2013)

Bipolar disorder recurrence prevention using self-monitoring daily mood charts: case reports from a 5 year period
por: Yasui-Furukori, Norio, et al.
Publicado: (2017)

Effect of age and disease on bone mass in Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ifmuli78up35pfs2dclhovof7b